21572 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF
#2Alpha Emitter Compositions And Methods
#3Albumin Conjugates and Process for Preparation thereof
#4ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF
#5CLEAVABLE RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF
#6Cleavable radioligands for targeting cell surface receptors and uses thereof
#7METHOD FOR PURIFICATION OF RADIOLABELED MACROAGGREGATED HUMAN SERUM ALBUMIN
#8THERAPEUTIC AGENT TARGETING HER2
#9COMPOSITIONS, DEVICES AND KITS FOR SELECTIVE INTERNAL RADIATION THERAPY
#10Oncolytic poliovirus for human tumors
#11Alpha emitter compositions and methods
#12IMAGING AGENTS FOR RADIOLABELING EXOGENOUS AND ENDOGENOUS ALBUMIN
#13IDENTIFICATION AND TREATMENT OF TUMORS CHARACTERIZED BY AN OVEREXPRESSION OF THE NEONATAL FC RECEPTOR
#14Oncolytic poliovirus for human tumors
#15CORROLE COMPOSITIONS
#16Method for labeling radioisotope radiolabeling compound and kit comprising the same for labeling radioisotope
#17PIGMENT-COUPLED MANNOSYL SERUM ALBUMIN COMPLEX AND LYMPH NODE-PROBING COMPOSITION COMPRISING SAME
#18POLYPEPTIDES
#19Oncolytic poliovirus for human tumors
#20INJECTION COMPOSITION FOR LABELING LESION
#21Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells
#22Oncolytic poliovirus for human tumors
#23Nanoparticles and method for manufacturing the same
#24COMPOSITION FOR IMAGING ATHEROSCLEROSIS AND METHOD FOR DIAGNOSING ATHEROSCLEROSIS BY USING SAME
#25RADIOACTIVE AGENT SYNTHESIS DEVICE AND METHOD
#26Polypeptides
#27KIT AND METHOD FOR QUICKLY PREPARING RADIO-ISOTOPE LABELED HUMAN SERUM ALBUMIN MICROSPHERES
#28Complex of mannosyl serum albumin, method of preparing the same, optical imaging probe and kit comprising the same
#29ONCOLYTIC POLIOVIRUS FOR HUMAN TUMORS
#30Labeling composition for cancer lesion
#31SET AND METHOD FOR THE PRODUCTION OF A RADIOPHARMACEUTICAL
#32Method of bonding gold nanoparticles with diethylenetriamine pentaacetic acid
#33Polypeptides
#34CONJUGATE OF HUMAN ALBUMIN AND 2-(4-ISOTHIOCYANATOBENZYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID USEFUL FOR THE LOCALIZATION OF RADIONUCLIDES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
#35Muteins of hNGAL and related proteins with affinity for a given target
#36Sentinel lymph node marker capable of multi-mode imaging
#37Method for making rhenium-186/188 labeled human serum albumin microspheres and kit for making the same and method for using the kit
#38METHODS AND COMPOSITIONS FOR DIAGNOSIS OF IGA-AND IGM-MEDIATED KIDNEY DISEASES
#39Modular transport platform for targeted delivery of therapeutic agents
#40Labelled biotin conjugates
#41Complex of bifunctional chelating agent and mannosyl human serum albumin
#42Muteins of hNGAL and related proteins with affinity for a given target
#43Methods for radiolabeling macromolecules
#44PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION
#45Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#46Hexatriene-β-carbonyl compound
#47Process for preparing particles of proteinaceous material
#48Peptide-based carrier devices for stellate cells
#49Radioisotope Labelled Biological Compositions, And Their Use In Accelerator Mass Spectrometry
#50Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them
#51Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them
#52Method for targeting cells involved in sclerotic and/or fibrotic diseases